 |
|
|
| |
High Efficacy of LDV/SOF Regimens for 12 Weeks
for Patients With HCV Genotype 3 or 6 Infection
|
| |
| |
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
Edward J. Gane,1 Robert H. Hyland,2 Di An,2 Evguenia S. Svarovskaia,2 Phillip S. Pang,2 William T. Symonds,2 John G. McHutchison,2 Catherine A. Stedman3
1Auckland Clinical Studies, Auckland, New Zealand; 2Gilead Sciences, Inc., Foster City, CA; 3Christchurch Clinical Studies Trust, Christchurch, New Zealand
|
| |
|
|
|
|
|
